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Abstract
The coronavirus disease-19 (COVID-19) virus has infected many people across the 
globe. The health system particularly medical laboratory has been overwhelmed by 
the pandemic, and many health professionals including medical laboratory profes-
sionals have lost their lives during the fight against the virus. Medical laboratory 
science is the bedrock of medical practice and the role of medical laboratory science 
in containing the COVID-19 pandemic cannot be overemphasized as they are also 
behind the testing of clinical specimens from infected and any recovered patients. As 
disease detectives, Medical laboratory scientists and other medical laboratory profes-
sionals’ role in the fight against the COVID-19 pandemic include; diagnosis, monitor-
ing, development of vaccines, testing protocols, testing kits, offering advice to the 
guide government policy on containment of the virus.: Various methods and tech-
niques such as virological cell culture, genomic sequencing, amplification, polymerase 
chain reaction (PCR) /gene Xpert systems, immunological testing, biosensors and 
rapid diagnostic techniques (RDTs) have been employed towards discovery, testing 
and epidemiology since the onset of COVID-19. The medical laboratory workers and 
other health workers are so visible at the COVID-19 frontline and are being recog-
nized and applauded for the role played in the recovery of patients affected with the 
virus. The medical laboratory component is very germane in the COVID-19 vaccine 
research and vaccination so as to provide pre- and post-vaccination laboratory data.
Keywords: COVID-19, laboratory testing, medical laboratory, involvements, 
interventions, technologies, medical laboratory scientists
1. Introduction
Medical laboratory is a very important component in public health practice and 
operation especially in case of COVID-19. Medical Laboratory Science practice 
involves the analysis of human specimen like body fluids, excretion and various body 
swabs for the purpose of medical laboratory diagnosis, treatment and research [1] of 
which coronavirus is the one under study. It is important to note that medical labora-
tory science can also be called Clinical Laboratory Science or Medical Laboratory 
Technology depending on the nomenclature in the countries of practice [2].
The historical trend of COVID-19 pandemic [3–6] has adequately placed medical 
laboratory services in a very critical aspect in containment of the disease across the 
globe. The medical laboratories play a critical role in the detection, management, 
disease surveillance and control in provision of accurate health data for national 
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planning and decision making and COVID-19 is not an exception. Timely access and 
geographical availability of COVID-19 diagnostic testing remains a challenge in the 
health system and could affect ongoing containment measures [7] for the COVID-19.
The first medical diagnosis made by humans were done by ancient scientists 
through observation with their physical senses. The ancient Greek attributed all 
diseases to disorders of bodily fluids called humors, and during late medieval 
period, then later with the advent of microscope, the microscopy procedure on such 
specimens have revealed more [8] followed by later technologies, automations, 
sophistications and molecular testing in the current age.
This chapter shall review the medical laboratory involvement and interven-
tion during COVID-19 era and the ongoing efforts towards supporting laboratory 
surveillance and response to COVID 19. It will equally show the capacity of medical 
laboratory perspectives in COVID-19 and provide more information on the medical 
laboratory testing strategy, towards developing and managing sudden capacities 
for testing relevant specimens at all levels of health system. Also, the approaches 
for ensuring laboratory testing sustainability in identifying new and suitable 
methods consistent with maximizing testing reagents, mobilizing human resources 
and guide towards implementation of public health measures towards COVID-19 
containment, while exploring the recognition and protection policies for medical 
laboratory professionals during COVID-19 shall be presented.
2.  Importance of medical laboratory during pandemic and public health 
issues
Obeta et al. [1] highlighted some importance of medical laboratory in public 
health matters to include rapid, accurate and prompt diagnosis for proper treatment 
and effective monitoring of patients’ response to treatment. Medical laboratory 
provides up to 70% informed decisions regarding patients’ hospital admissions and 
discharge. It guides physicians, nurses and other healthcare workers in choosing the 
correct laboratory tests and ensure the proper sample collection. Medical labora-
tory services equally carry out equipment installation, validation and repay in the 
healthcare laboratories. Medical laboratory component is key in infectious diseases 
surveillance like Ebola, Tuberculosis, HIV, Malaria and now COVID-19. Quality 
assurance of a healthcare facility and public health in general is made possible by 
medical laboratory research towards quality improvement.
Researches [1, 8–10] have shown the main functions of medical laboratory  
during the COVID-19 pandemic to include the following:
• Establishing appropriate accurate, and sustainable diagnostic testing capacities 
to respond to COVID-19 needs
• Ensuring surge (sudden) capacity to process a large volume of specimens to 
cope with COVID-19 epidemiological response needs.
• Conducting virological monitoring of the pandemic at local, state, national, 
regional and global levels.
• Ensuring timely release of laboratory data and linking data with surveillance 
data to inform public health decision making and response activities.
• Tracking the genetic evolution of COVID-19 and contributing in research and 
development of vaccines by characterization of viruses
3
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To achieve adequate COVID-19 monitoring and surveillance, there is need for 
widespread and continuous testing of not only suspected cases or contacts, but 
even asymptomatic and apparently healthy population in order to achieve adequate 
COVID-19 trend monitoring in context of rapid human-to-human spread, and 
prompt identification of cases.
Undoubtedly, there are many benefits of large-scale population testing for 
COVID-19 as demonstrated in many high-income countries. For countries that have 
numerous challenges in their health care delivery system in terms of medical labora-
tory diagnostics, house-to-house case searching and community contact tracing for 
infectious diseases surveillance is adequate.
Medical Laboratory plays a crucial role in monitoring co-morbidities, diagnosing 
complications, assessment of treatment responses and assessing the disease preva-
lence in the community. Advancement of molecular techniques is mainly relying on 
understanding the genomic and proteomic composition of COVID-19.
WHO [5, 7] emphasizes “detect, protect and treat” to break the chain of trans-
mission of SARS-COV-2 and COVID-19. Early medical laboratory testing and 
immediate treatment significantly decrease future COVID-19 cases. Medical labora-
tory assessment reveals diagnoses, confirms or rules out prognosis based on signs 
and symptoms, determines severity, monitors treatment responses or complications 
in COVID-19. The role of medical laboratories is more evident globally today as the 
battle against COVID-19 rages.
3. Medical laboratory and research towards discovery of COVID-19
On December 31, 2019, China alerted the WHO about the occurrence of several 
cases of an unusual pneumonia caused by an unknown virus among persons who 
had either visited or had consumed food from the live animal market in Wuhan 
city of China, the epicenter of the outbreak. Since then, the infection has spread to 
other Chinese cities as well as internationally, resulting in the current pandemic. On 
January 7, 2020, the WHO announced they had identified a new virus. The novel 
virus was named 2019-COV and was identified as member of the coronaviridae 
family which also includes SARS and MERS. China announced its first death from 
the virus on January 23, 2020 as rail and air departure were suspended on January 
30, WHO declared the outbreak a global health emergency [4, 5, 7].
The medical laboratory has been duly involved and its involvement ranges from 
the discovery the pneumonia like virus to the description as SARS and MERS in 
nature, viral characterization and sequencing and the naming of the viral disease 
as new coronavirus and COVID-19 [11]. The role of the medical laboratory services 
from COVID-19 discovery to the management cannot be over emphasized.
4.  Challenges and way forward for medical laboratory practice in 
COVID-19 era
There is no doubt that COVID-19 is new and so are the technologies for testing and 
research. COVID-19 era is filled with operational differences between the medical 
laboratory developed protocols and new commercial consumables protocols follow-
ing the COVID-19 pandemic. However, the implementation of those new protocols 
is challenging and requires continuous training for the laboratory staff [12]. Another 
challenge is limited access to COVID -19 reagents. This restricted the number of testing 
of citizens to those that were having symptoms or at risk as there is fear of exhausting 
the limited COVID-19 reagents and consumables. In the testing proper, there is delayed 
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outbreak detection and reporting of COVID -19 cases maybe due to distance from 
testing and collection sites and the technicalities involved. Also there is limited access to 
clinically validated or regulatory approved molecular and serologic tests either through 
the WHO network, national regulators or through commercial manufacturers [13, 14].
As COVID-19 ravages the world, there are shortages and difficulties in 
importing large diagnostic kits in the country. There is also poor knowledge and 
research capacity on COVID-19. Aside from technical difficulties associated with 
COVID-19 testing, certain seasonal changes might equally affect the number 
of tests [9]. Table 1 discusses the challenges and way forward towards offering 
COVID-19 medical laboratory services.
5.  Medical laboratory methods, techniques and technologies applied for 
COVID-19 testing
The medical laboratory methods and technologies applied in testing COVID-19 
includes: neutralization/virological cell culture test, COVID-19 genomic sequencing, 
nucleic acid testing (NAT) /amplification testing, polymerase chain reaction (PCR), real 
time PCR (RT- PCR) and Gene Xpert systems, immunological testing, biosensors, rapid 
diagnostic techniques (RDTs) [15]. These methods are illustrated in Figure 1.
S/N Challenges Way forward
1 Misdiagnosis of COVID-19 due to 
poor training or use of quacks
Adequate training of qualified professionals
2 Poor working environment Construct modern Medical Laboratory working 
environment
3 Poor working tools and 
equipment
Procure modern tools and equipment
4 Unstable power supply Stabilize power supply and have a standby power supply or 
an alternative power
5 Poor team work among health 
professionals
Instill team spirit among practitioners
6 Lack of political will towards 
medical laboratory practices
Politicians should learn from COVID-19 lockdown to have 
the will to update medical laboratory facilities as they could 
be clients in such facilities
7 Corruption Kill corruption surrounding COVID-19
8 Haphazard quality system Standardize quality system
9 New technologies and 
technicalities associated with 
COVID-19
Imbibe new technologies and technicalities from the 
producers
10 Paucity of fund in COVID-19 
laboratory services
Fund the medical laboratory services to the full with 
regards to COVID-19 and associated services
11 Unavailability of local testing kits Give grant and fund research for production of local testing 
kits
12 Different countries have little no 
validated rapid kits
Mandate the regulatory bodies to validate more rapid kits 
to boost testing
13 Poor knowledge and research 
capacity
Encourage more research in laboratories
14 Non-involvement of medical 
laboratory component in COVID-
19 vaccination
Involve medical laboratory component to give a basal 
parameter before vaccination and after some days of 
vaccination to assist in post vaccine research
Table 1. 
Challenges and way forward for medical laboratory practice in COVID-19 era.
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Basically, virological cell culture test is the gold standard for virus discovery, 
pathogenesis research and strategy evaluation but since the emergence of COVID-19, 
PCR has been adopted as the gold standard and has been in use globally considering 
the shorter turnaround time. Genomic sequencing uses sophistication to track the 
Figure 1. 
Diagnostic methods and technologies employed in COVID-19 testing. KEY: CBPB, cell-based potentiometric 
biose; CLIA, Chemiluminescence immunoassay; ddPCR, droplet digital PCR; E-gene, envelope protein gene; 
ELISA, enzyme-linked immunosorbent assay; FET, field effect transistor; IFA, Immunoflorescence assay; 
LAMP, loop mediated isothermal amplification; LFIA, lateral flow immunoassay; LSPR, localized surface 
plasmon resonance (sensor); MCLIA, magnetic Chemiluminescence enzyme immunoassay; M, membrane 
protein gene; N-gene, Nucleocapsid protein gene; NAT, nucleic acid testing; PCR, polymerase chain reaction; 
ORF, open reading frame; OSN-qRT, PCR - one step nested RT-PCR; qRT-PCR, real-time quantification PCR; 
RDT, rapid diagnostic technique; RdRp, RNA-dependent RNA polymerasegene; S, spike proteins.
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pandemic and aids vaccine development [16]. Immunological testing is based on the 
quantification and detection of antigen and antibody interactions. Biosensors use 
selectivity features of a bimolecular and sensitivity of physiochemical transducers in 
COVID-19 testing. Rapid Diagnostic Techniques (RDTs) are new technologies which 
apply some of the above mentioned techniques to achieve shortest turnaround time 
and accessibility. Although each method has its advantages and disadvantages, it is 
advisable to employ at least two methods [15, 17–19] for quality medical laboratory 
testing especially when using RDTs as shown in Figure 2.
6. Medical laboratory interventions in COVID-19
As part of the global response to the COVID-19 pandemic, medical laboratory 
diagnosis has remained the corner stone to this intervention. Molecular assays 
performed on nasopharyngeal swab or other upper respiratory tract specimen are 
the most commonly used and reliable test for the diagnosis of COVID-19. A variety 
of RNA gene targets are used by different molecular assays.
The processes from sample collections, sample transport and actual testing 
for COVID-19 remains very important including all quality system measures put 
in place to ensure reliability and sensitivity. The medical laboratory research uses 
samples from nasopharyngeal swabs, oropharyngeal swabs, throat swabs, saliva, 
sputum, bronchoalveolar lavage fluid, conjunctival swabs, rectal swabs, whole 
blood, serum/plasma, stool, and urine [15].
It is evident that medical laboratory parameters have been adequately employed 
to access diagnosis like increased neutrophil, aspartate aminotransferase, alanine 
aminotransferase, C-reactive protein, lactate dehydrogenase and urea. There is also 
decrease in procalcitonin, albumin, and white blood cells like leukocytes, and lym-
phopenia and eosinopenia have been noted among COVID-19 patients. Also, medical 
Figure 2. 
NCDC medical laboratory testing algorithm in Nigeria while using RDTs.
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laboratory parameters have been employed in the assessment of the severity of the 
COVID-19 such as interleukin-6 (IL-6), d-dimer (d-D), glucose, fibrinogen, throm-
bin time, and C-reactive protein and fibrinogen. Some parameters are predictors 
during prognosis like IL-6 and D-Dimer, absolute lymphocyte count, lactate dehydro-
genase, creatine kinase and absolute monocyte count which can predict whether the 
patient can be admitted into intensive care unit or not. During treatment, laboratory 
parameters are used to assess improvement in treatment and complications. For 
example; reduction in aspartate aminotransferase, alanine aminotransferase, creatine 
kinase and dehydrogenase shows response to treatment while increased procalcitonin 
and C-reactive protein indicates liver abnormality, high D-dimer, fibrinogen, pro-
thrombin time predicts thromboembolism and new-onset renal failure [17, 20].
A medical laboratory, irrespective of location, modern, sophisticated or molecu-
lar in nature in the aspect of COVID-19 fight, has a huge role to play especially in 
the local certain where COVID19 testing has not reached. Many in such area may 
not know their status and no wonder the presence of a knowledgeable Scientist shall 
corroborate the medical laboratory implications of COVID-19 to be able to approach 
every client and sample in a safe and professional way.
There is always a manual that help members, states and partners as they set 
up comprehensive quality assurance measures for COVID-19 testing laboratory 
network. The guidance emphasizes the use of standardized registration formats as 
quality tool, Quality control (QC), enrollment of laboratories in external quality 
assessment (EQA) schemes and issues of external quality assessment performance 
data for continuous quality improvement of COVID-19 testing laboratories. It is an 
essential resource for a medical laboratory personnel to be involved in day-to-day 
testing of COVID-19.
Figures 2 and 3 shows testing Algorithm for Nigeria while using RDTs and 
approved medical laboratories (75–25 Gene Xpert and 50 PCR Labs) for COVID-19 
respectively as released by Nigeria Centre for Disease Control (NCDC).
In medical laboratory testing of COVID-19, each country adopts their protocol 
based on targeted proteins as it suits them based on available testing techniques 
and methodology and as well the laboratory set ups and environment. For instance, 
Figure 3. 
NCDC approved medical laboratories for COVID-19 as at 23rd February, 2021.
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USA protocol for testing targets N (N1, N2, N3) genes and Rp-RNase; China targets 
ORF 1ab and N-genes, Nigeria targets N-genes and ORF 1ab; Germany RdRp, E and 
N-genes, Japan and Thailand targets N-genes while Hong Kong targets ORF 1b-nsp-
14 and N-genes [15, 17].
7. Recognition of medical laboratory professionals during COVID-19
The world biomedical day of 2020 awareness was solely dedicated to medical 
laboratory professionals across the globe because of their unique role in COVID-19.
In Nigeria and other countries, the emphasis on Testing is more of the recogni-
tion of the medical laboratories and professionals who toil to discover, test, monitor 
and research further towards COVID-19 elimination. Usually, medical laboratory 
professionals are not noticed for their great contribution to healthcare. They are 
rarely seen by people for their heroic contribution to patients’ healthcare but can-
not be underestimated as they perform series of tests that are crucial to ensuring 
accurate diagnosis and treatments that can help save patients’ lives.
Medical laboratory professionals play a critical role in the diagnostics and test-
ing of COVID-19 which they perform every day. A collaborative committee of 17 
medical organizations including American Society for Clinical Laboratory Science 
(ASCLS), Association of Medical Laboratory Scientists of Nigeria (AMLSN) and 
American Society of Microbiology (ASM) in the year 2020 helped to coordinate 
the celebration of annual Biomedical science day in April, 2020 to increase public 
understanding of and appreciation for clinical laboratory personnel as COVID-19 
rages worldwide [21]. Such recognitions usually come from government, organiza-
tions or various individuals all over the world.
Laboratory professionals use specialized instruments and techniques to analyze 
patient samples, such as blood, urine, body fluids, tissues and stool. They may be 
in a laboratory located in the hospital where the patient may be hundreds of miles 
away in a reference laboratory, however, no matter their distance to the patient, they 
produce results that directly affect the patient care. In addition to their day to day 
activities, laboratory professionals tackle threats to our national security and health 
such as disease outbreaks. They have played critical roles in fight against COVID-19. 
These effort have been appreciated by many governments across the globe [22, 23].
“We really need to hail the pathologist, medical technologists, and other laboratory 
professionals who are becoming unsung heroes of the COVID-19 pandemic” [21].
Now more than ever, is the chance for people all round the world to thank our 
unseen medical laboratory heroes and heroines. Each year medical laboratory 
professional’s week celebrates the people who provides critical diagnostic informa-
tion to help save lives and shows appreciation for the vital work they performed. 
Across the world, everyday people are applauding the brave health care workers on 
the front lines of the COVID-19 pandemic.
8.  Effort towards protection of medical laboratory and other health 
workers during COVID-19
Protecting Health Care Workers (HCWs) during routine care of suspected or 
confirmed COVID-19 patients is of paramount importance during the pandemic. 
The protection ranges from adequate provision of personal protective equipment 
to provision of temporary accommodation to carter for during testing and treat-
ment of COVID-19 patients outside homes, Life insurance packages, Special Hazard 
Allowances and other allowances and Commencement of Vaccination among 
9
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laboratory professionals/healthcare workers. In Nigeria, life insurance to medical 
laboratory scientists during the COVID-19 was given by the government through 
the Federal Ministry of Health (FMOH) as seen in Figure 4 as a clarification that the 
profession is among the front line healthcare workers targeted in the programme.
Countries may differ in their approach to laboratory and healthcare workers pro-
tection and care during the COVID-19 as documented by several authors [24–30] 
and analyzed in Table 2. Such support may involve mental health support provided 
Figure 4. 














S/N Countries Government/employee support programme packages
Mental 
health
Salary Childcare COVID-19 
allowance










1 Australia A A A A A A A A NS A NS A [28]
2 Bulgaria A A NA A NS NS NS NA NS A NA A [27]
3 Canada A A NA A NS NS NS NA NS A NA A [24]
4 China A A NS A NS NS NS NS NS A NA A [30]
5 Denmark A A A NA NS NS NS NS NS A NA A [27]
6 Finland A A NA NA NS NS NS NS NS A NS A [27]
7 France A A A A NS NS NS NS NS A NS A [27]
8 Germany A A A A NS NS NS NS NS A NS A [27]
9 Ghana A A NS A A NS NS A NS A A A [29]
10 Israel A A A NA NS NS A A NS A A A [27]
11 Lithuania A A A A A A A A NS A A A [27]
12 Malta A A A A NS A A A NS A A A [27]
13 Nigeria A A NA A A P NS A NA A A A
14 Romania A A A A NS A A A A A A A [27]
15 UK A A A A NS A NS A NS A NS A [27]
16 USA A A A A NS A NS A NS A A A [24]
KEY: A, Available; NA, Not available; NS, Not sure; P, Partial.
Table 2. 
Employee support (assistance) programmes by some countries for COVID-19.
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by psychiatrists and psychologists to medical laboratory staff and other healthcare 
workers working on the frontline which may be in form of counseling or in-house 
psychologists outreach.
Employee support programme (ESP) or employee assistant programme (EAP) 
cannot be exhausted and depends on the government, private institutions or the 
healthcare workers involved. The list may include: mental health, salary, childcare, 
COVID-19 allowance, insurance, food, transport, accommodation, continuous 
professional development (CPD) units, online training, spiritual support in form of 
prayers, social lives using music and dancing and others as may be necessary.
Financial support, payment of salaries and job retention for Medical Scientists 
and other healthcare workers is a sine qua non, so that healthcare workers who were 
required to stay at home on preventive quarantine or levels of exposure are pro-
tected to receive their basic pay and class/grade allowances. Special allowances for 
COVID-19 are paid to frontline workers in Nigeria and other countries.
9. Conclusion
No doubt the COVD-19 is now a pandemic and the virus is really testing the 
resilience of our health delivery system. Medical laboratory science as the bedrock 
of diagnostic medicine and the role of medical laboratory science in containing any 
pandemic cannot be relegated to the background, not now or in the future. There is 
an urgent need to re-strategize in the effort towards fighting COVID-19 especially 
with regards to medical laboratory diagnosis as well as major component in infec-
tious disease control globally.
All healthcare providers remain in the dark until the release of the medical 
laboratory test result on any new public health challenge COVID-19 as an example. 
Quality tools/equipment and conducive working environment provides quality 
results during public health challenges as noted during this COVID-19 pandemic.
The development of local medical laboratories to international standard are 
very germane to politicians as COVID-19 discourages medical tourism. Medical 
laboratories could do better with motivational packages such as recognition, hazard 
allowances and life insurance policies.
Severe Acute Respiratory Syndrome coronavirus-2 (SARS-COV-2) infection is a 
global pandemic. Health care workers role in patient management is predisposing 
and can serve as the means of hospital and community transmission.
Vast majority of health care workers are taking precautionary measures such 
as avoiding crowded places, washing of hands and the use of personal protective 
equipment (PPE) against coronavirus infection. This knowledge and attitude of 
health care workers shows excellent knowledge and possessed a positive attitude 
and good health practice towards the prevention of COVID-19. It is recommended 
that health care education of health care workers should continue in order to 
prevent and control infection.
Medical laboratory testing is very vital in public health emergencies [19] and in 
COVID-19 in particular thereby encouraging medical laboratory strengthening [31, 32], 
towards overcoming all laboratory associated challenges in COVID-19 [33–36].
This chapter hereby recommends the following:
a. Healthcare providers should always rely on the medical laboratory testing 
results in all public health issues and not only on COVID-19
b. There is need to update and quality crosscheck of all COVID-19 testing kits and 
equipment
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c. Adequate construction and update of medical laboratory facilities in use for 
COVID-19 and other public health issues
d. Institutions involved in COVID-19 should sort for scientific and empirical data 
for all public health issues and vaccination as guide to public health policies
e. Government should provide and pay good hazard allowances and life insurance 
to all medical laboratory professionals
f. Train and retrain all medical laboratory professionals to be at the same pace 
with any upcoming wave of COVID-19
g. Adequate policies should be employed to stem out various challenges affecting 
optimum performance of various medical laboratories across the globe
h. Knowing fully well that Scientists contributed to the vaccine production 
research, it should be most appropriate that COVID-19 antibody testing should 
be carried out on individuals before vaccination to determine status. Not only 
that, various medical laboratory parameters should be carried out on all that 
are receiving vaccine before and after vaccine administration to help track 
changes and monitor health status of individuals who have received the vaccine 
candidates available currently for COVID-19.
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